Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 1yr
Pharmaceutical/Medical - Page 4
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 1yr
Arrival of Tim Powell continues US firm’s European IP push | 1yr
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 2yrs
This second edition, written by leading ESG legal specialists, provides an up-to-date jurisdictional ... | 1yr
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 2yrs
Charles Atkinson to replace Todd Kingma, who retires from Perrigo for a second time | 2yrs
Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 2yrs
The way the request was processed still raises ‘significant concerns’, says the firm | 2yrs
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 2yrs
Pan-European patent court delivers first revocation judgment a year and a month after opening | 2yrs
Any regulatory changes to drug patents and pricing should be wary of stifling innovation, writes Neal Gerber Eisenberg lawyer Thomas Campbell | 2yrs
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 2yrs
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 2yrs
Mathys & Squire patent litigator Stephen Garner discusses changes to EU pharmaceutical legislation and the impact on IP rights | 2yrs
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 2yrs
Swedish companies are imposing age restrictions on their beauty products. Bird & Bird lawyers Caroline Grotenfelt, Julia Jansson and Beatrice Rälg ask if more countries will follow suit? | 2yrs
Team moves over from Lerner David strengthening medical device practice | 2yrs
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 2yrs
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2yrs
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2yrs